T4K3.news
Tana Mongeau warns against Mounjaro use
Tana Mongeau shares her negative experience with Mounjaro, advising against its use for weight loss.
Tana Mongeau has warned people against using Mounjaro for weight loss, after experiencing crippling side effects on the medication.
Tana Mongeau warns against using Mounjaro for weight loss
Influencer Tana Mongeau recently advised against using Mounjaro for weight loss, citing severe side effects she experienced. Initially designed for managing Type-2 diabetes, Mounjaro has gained popularity among those looking to lose weight. It contains tirzepatide, which suppresses appetite and regulates blood sugar. Mongeau, in a recent podcast episode, shared that while she lost 6 pounds in just two days, she suffered from intense nausea and fatigue, requiring prescription medication to cope. Users might also face other side effects, including hair loss and constipation. Mounjaro is typically prescribed for individuals with a body mass index of 40 or higher, but some have managed to obtain it through private pharmacies. Eli Lilly, the drug's manufacturer, emphasized that patient safety is their main focus and encouraged users to consult healthcare professionals regarding side effects.
Key Takeaways
"This is the biggest public service announcement to the whole wide world to never, ever, ever do it."
Mongeau's statement highlights her strong warning against the risks of Mounjaro.
"I should not have done that."
Mongeau reflects on her regret about using Mounjaro, despite the rapid weight loss.
"Patient safety is Lilly’s top priority."
Eli Lilly's response underscores their commitment to safety amid concerns about Mounjaro.
"Like, dying. Like, crawling on the floor."
Mongeau vividly describes her physical state while on Mounjaro, illustrating severe discomfort.
Mongeau's warning reflects a growing trend of public figures discussing their personal experiences with weight-loss medications. While Mounjaro is gaining traction for its rapid effects, the potential side effects raise serious questions about its long-term safety and appropriateness for weight loss. As more people seek quick fixes, the risks associated with fast weight loss become increasingly relevant in health discussions. Public reactions to these warnings could lead to increased scrutiny of the marketing of weight-loss drugs, particularly given Mongeau's influential platform among young audiences who might be considering such medications.
Highlights
- Never, ever do it. I have been dying this week.
- Anything that’s a quick fix, obviously, it works well.
- I shot up Mounjaro, and this is the result.
- I had to sleep for over 12 hours at a time.
Concerns about Mounjaro and potential side effects
Mongeau's warning sheds light on the severe side effects of Mounjaro, leading to questions about safety for weight-loss use.
As conversations around health and medication grow, caution remains vital.
Enjoyed this? Let your friends know!
Related News
Tana Mongeau issues warning about Mounjaro
Warnings issued for Mounjaro users about undereating
Growing panic among Mounjaro users due to shortages
Surgeon raises alarm on weight loss drug abuse
Teens weight loss injections raise safety concerns
Demand for weight loss drugs exceeds supply in the UK
Weight-loss drugs linked to increased eating disorders in the US
Patients face challenges in accessing Mounjaro and Wegovy on the NHS
